Advertisement
QGEN or SIBN or SLNO
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
QGEN’s FA Score shows that 0 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s), and SLNO’s FA Score reflects 0 green FA rating(s).
- QGEN’s FA Score: 0 green, 5 red.
- SIBN’s FA Score: 0 green, 5 red.
- SLNO’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
QGEN’s TA Score shows that 2 TA indicator(s) are bullish while SIBN’s TA Score has 3 bullish TA indicator(s), and SLNO’s TA Score reflects 3 bullish TA indicator(s).
- QGEN’s TA Score: 2 bullish, 6 bearish.
- SIBN’s TA Score: 3 bullish, 6 bearish.
- SLNO’s TA Score: 3 bullish, 5 bearish.
Price Growth
QGEN (@Medical Specialties) experienced а -0.84% price change this week, while SIBN (@Medical Specialties) price change was -6.88% , and SLNO (@Biotechnology) price fluctuated -1.96% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.
Reported Earning Dates
QGEN is expected to report earnings on Nov 04, 2025.
SIBN is expected to report earnings on Nov 10, 2025.
SLNO is expected to report earnings on Nov 05, 2025.
Industries' Descriptions
@Medical Specialties (-1.00% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Biotechnology (+2.69% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| QGEN | SIBN | SLNO | |
| Capitalization | 9.52B | 672M | 4.41B |
| EBITDA | 689M | -34.45M | -194.63M |
| Gain YTD | 10.204 | 20.685 | 85.962 |
| P/E Ratio | 27.85 | N/A | N/A |
| Revenue | 1.97B | 139M | 0 |
| Total Cash | 1.06B | 166M | 290M |
| Total Debt | 1.53B | 39M | 52.8M |
QGEN | SIBN | SLNO | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 15 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 70 | 100 | 38 | |
SMR RATING 1..100 | 100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 48 | 47 | 39 | |
P/E GROWTH RATING 1..100 | 100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 85 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
QGEN's Valuation (50) in the Medical Specialties industry is in the same range as SIBN (50) and is in the same range as SLNO (50). This means that QGEN's stock grew similarly to SIBN’s and similarly to SLNO’s over the last 12 months.
SLNO's Profit vs Risk Rating (38) in the Medical Specialties industry is in the same range as QGEN (70) and is somewhat better than the same rating for SIBN (100). This means that SLNO's stock grew similarly to QGEN’s and somewhat faster than SIBN’s over the last 12 months.
SLNO's SMR Rating (100) in the Medical Specialties industry is in the same range as QGEN (100) and is in the same range as SIBN (100). This means that SLNO's stock grew similarly to QGEN’s and similarly to SIBN’s over the last 12 months.
SLNO's Price Growth Rating (39) in the Medical Specialties industry is in the same range as SIBN (47) and is in the same range as QGEN (48). This means that SLNO's stock grew similarly to SIBN’s and similarly to QGEN’s over the last 12 months.
SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as SIBN (100) and is in the same range as QGEN (100). This means that SLNO's stock grew similarly to SIBN’s and similarly to QGEN’s over the last 12 months.
| QGEN | SIBN | SLNO | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 39% | 1 day ago 80% | 1 day ago 82% |
| Stochastic ODDS (%) | 1 day ago 52% | 1 day ago 81% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 52% | 1 day ago 85% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 55% | 1 day ago 84% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 52% | 1 day ago 78% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 53% | 1 day ago 80% | 1 day ago 89% |
| Advances ODDS (%) | 7 days ago 57% | 6 days ago 79% | 1 day ago 87% |
| Declines ODDS (%) | 9 days ago 51% | 1 day ago 80% | 8 days ago 85% |
| BollingerBands ODDS (%) | 1 day ago 56% | 1 day ago 76% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 50% | 1 day ago 75% | 1 day ago 90% |
Advertisement
QGEN and
Correlation & Price change
A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with A. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then A could also see price increases.
| Ticker / NAME | Correlation To QGEN | 1D Price Change % | ||
|---|---|---|---|---|
| QGEN | 100% | -1.72% | ||
| A - QGEN | 63% Loosely correlated | -5.95% | ||
| TMO - QGEN | 62% Loosely correlated | -3.88% | ||
| BRKR - QGEN | 62% Loosely correlated | -2.89% | ||
| RVTY - QGEN | 61% Loosely correlated | -2.61% | ||
| DHR - QGEN | 59% Loosely correlated | -2.47% | ||
More | ||||
SIBN and
Correlation & Price change
A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with UFPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then UFPT could also see price increases.
| Ticker / NAME | Correlation To SIBN | 1D Price Change % | ||
|---|---|---|---|---|
| SIBN | 100% | -2.31% | ||
| UFPT - SIBN | 45% Loosely correlated | -5.86% | ||
| AORT - SIBN | 45% Loosely correlated | -1.55% | ||
| TMCI - SIBN | 44% Loosely correlated | -4.01% | ||
| ATRC - SIBN | 43% Loosely correlated | -2.43% | ||
| KIDS - SIBN | 43% Loosely correlated | -0.63% | ||
More | ||||
SLNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.
| Ticker / NAME | Correlation To SLNO | 1D Price Change % | ||
|---|---|---|---|---|
| SLNO | 100% | +1.00% | ||
| BRNS - SLNO | 56% Loosely correlated | N/A | ||
| KANT - SLNO | 45% Loosely correlated | N/A | ||
| NKTX - SLNO | 42% Loosely correlated | -3.70% | ||
| SYRE - SLNO | 42% Loosely correlated | -6.70% | ||
| IDYA - SLNO | 40% Loosely correlated | -5.09% | ||
More | ||||